- Home
- PRGS vs CLDX Comparison
PRGS vs CLDX Comparison
Compare PRGS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGS | CLDX |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | United States |
| Employees | 2815 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1991 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PRGS | CLDX |
|---|---|---|
| Price | $43.94 | $27.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $68.00 | $43.80 |
| AVG Volume (30 Days) | 506.9K | ★ 775.5K |
| Earning Date | 01-20-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | ★ $940,126,000.00 | $2,599,000.00 |
| Revenue This Year | $32.42 | N/A |
| Revenue Next Year | $1.44 | $19.70 |
| P/E Ratio | $40.98 | ★ N/A |
| Revenue Growth | ★ 31.41 | N/A |
| 52 Week Low | $39.00 | $14.40 |
| 52 Week High | $69.88 | $30.50 |
Technical Indicators
Market Signals| Indicator | PRGS | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.62 | 50.50 |
| Support Level | $43.87 | $27.51 |
| Resistance Level | $45.49 | $28.79 |
| Average True Range (ATR) | 1.02 | 1.30 |
| MACD | 0.36 | -0.05 |
| Stochastic Oscillator | 70.44 | 28.48 |
Price Performance
Historical ComparisonAbout PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.